
|Articles|January 1, 2016
- Pharmaceutical Executive-01-01-2016
- Volume 36
- Issue 1
Pharmaceutical Executive, January 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Feeling the Heat: Pharm Exec's 2016 Industry Forecastalmost 10 years ago
Ferring: The Quiet Companyalmost 10 years ago
Feel the Earth Move Under Your Brand?about 10 years ago
Is the Hatch-Waxman System Broken?about 10 years ago
2015 FDA Drug Approvalsabout 10 years ago
Rough Road Ahead for Innovationabout 10 years ago
Country Report: Puerto RicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Bristol Myers Squibb Focuses on the Next Decade
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5




